Lung Cancer Epidemiology, Risk Factors and The Role of ZNF24

Authors

  • Xizun Tang

DOI:

https://doi.org/10.54097/1chp8k06

Keywords:

lung cancer, epidemiology, risk factors, genetics, ZNF24.

Abstract

Lung cancer is still one of the top cancer types that require worldwide effort in screening and prevention, as well as development of treatment. In this paper, the epidemiology of lung cancer has been summarized and the risk factors contributing to lung cancer have been discussed. In addition, a novel target for lung cancer treatment - ZNF24, has been discussed in brief.

Downloads

Download data is not yet available.

References

[1] P. Kanavos, “The rising burden of cancer in the developing world,” Ann. Oncol., vol. 17, pp. viii15–viii23, Jul. 2006, doi: 10.1093/annonc/mdl983.

[2] V. Sopik, “International variation in breast cancer incidence and mortality in young women,” Breast Cancer Res. Treat., vol. 186, no. 2, pp. 497–507, Apr. 2021, doi: 10.1007/s10549-020-06003-8.

[3] C. Wild, E. Weiderpass, and B. Stewart, Eds., World Cancer Report: Cancer Research for Cancer Prevention., vol. 2020. Lyon, France: International Agency for Reseach on Cancer. [Online]. Available: http://publications.iarc.fr/586

[4] A. G. Nicholson et al., “The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015,” J. Thorac. Oncol., vol. 17, no. 3, pp. 362–387, Mar. 2022, doi: 10.1016/j.jtho.2021.11.003.

[5] O. Lababede and M. A. Meziane, “The Eighth Edition of TNM Staging of Lung Cancer: Reference Chart and Diagrams,” The Oncologist, vol. 23, no. 7, pp. 844–848, Jul. 2018, doi: 10.1634/theoncologist.2017-0659.

[6] N. Howlader, “SEER Cancer Statistics Review, 1975-2010, National Cancer Institute”, [Online]. Available: https://seer.cancer.gov/archive/csr/1975_2010/

[7] H.-J. Haussmann and M. W. Fariss, “Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se,” Crit. Rev. Toxicol., vol. 46, no. 8, pp. 701–734, Sep. 2016, doi: 10.1080/10408444.2016.1182116.

[8] P. G. Shields et al., “A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation,” Cancer Epidemiol. Biomarkers Prev., vol. 26, no. 8, pp. 1175–1191, Aug. 2017, doi: 10.1158/1055-9965.EPI-17-0358.

[9] “Can electronic-cigarette vaping cause cancer?,” J. Cancer Biol., vol. 2, no. 3, Oct. 2021, doi: 10.46439/cancerbiology.2.027.

[10] Y. Li and S. S. Hecht, “Carcinogenic components of tobacco and tobacco smoke: A 2022 update,” Food Chem. Toxicol., vol. 165, p. 113179, Jul. 2022, doi: 10.1016/j.fct.2022.113179.

[11] D. Moir et al., “A Comparison of Mainstream and Sidestream Marijuana and Tobacco Cigarette Smoke Produced under Two Machine Smoking Conditions,” Chem. Res. Toxicol., vol. 21, no. 2, pp. 494–502, Feb. 2008, doi: 10.1021/tx700275p.

[12] R. C. Callaghan, P. Allebeck, and A. Sidorchuk, “Marijuana use and risk of lung cancer: a 40-year cohort study,” Cancer Causes Control, vol. 24, no. 10, pp. 1811–1820, Oct. 2013, doi: 10.1007/s10552-013-0259-0.

[13] L. R. Zhang et al., “Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium,” Int. J. Cancer, vol. 136, no. 4, pp. 894–903, Feb. 2015, doi: 10.1002/ijc.29036.

[14] J. D. Stanaway et al., “Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017,” The Lancet, vol. 392, no. 10159, pp. 1923–1994, Nov. 2018, doi: 10.1016/S0140-6736(18)32225-6.

[15] R. J. Hung et al., “A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25,” Nature, vol. 452, no. 7187, pp. 633–637, Apr. 2008, doi: 10.1038/nature06885.

[16] [16] M. Huang, Y. Chen, D. Han, Z. Lei, and X. Chu, “Role of the zinc finger and SCAN domain-containing transcription factors in cancer,” Am. J. Cancer Res., vol. 9, no. 5, pp. 816–836, 2019.

[17] Z.-G. Han et al., “Molecular Cloning of Six Novel Krüppel-like Zinc Finger Genes from Hematopoietic Cells and Identification of a Novel Transregulatory Domain KRNB,” J. Biol. Chem., vol. 274, no. 50, pp. 35741–35748, Dec. 1999, doi: 10.1074/jbc.274.50.35741.

[18] X. Liu et al., “MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer,” Oncotarget, vol. 6, no. 28, pp. 25418–25428, Sep. 2015, doi: 10.18632/oncotarget.4456.

[19] B. Pang, Y. Wang, and X. Chang, “A Novel Tumor Suppressor Gene, ZNF24, Inhibits the Development of NSCLC by Inhibiting the WNT Signaling Pathway to Induce Cell Senescence,” Front. Oncol., vol. 11, p. 664369, Jul. 2021, doi: 10.3389/fonc.2021.664369.

[20] L. Liu et al., “In vivo genome-wide CRISPR screening identifies ZNF24 as a negative NF-κB modulator in lung cancer,” Cell Biosci., vol. 12, no. 1, p. 193, Dec. 2022, doi: 10.1186/s13578-022-00933-0.

Downloads

Published

24-12-2024

How to Cite

Tang, X. (2024). Lung Cancer Epidemiology, Risk Factors and The Role of ZNF24. Highlights in Science, Engineering and Technology, 123, 410-416. https://doi.org/10.54097/1chp8k06